These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25803686)

  • 21. [Cox-2 and CD105 expression in breast cancer and disease-free survival].
    Grudzinski M; Cambruzzi E; Lahude E; Savaris RF; Pedrini JL; Zettler CG
    Rev Assoc Med Bras (1992); 2006; 52(4):275-80. PubMed ID: 16967149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma].
    Pang D; Liu F; Xue YW; Zhang QF
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
    Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
    Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer.
    Gwak JM; Jang MH; Kim DI; Seo AN; Park SY
    PLoS One; 2015; 10(4):e0125728. PubMed ID: 25884955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
    Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
    Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast.
    Westhoff CC; Jank P; Jacke CO; Albert US; Ebrahimsade S; Barth PJ; Moll R
    Virchows Arch; 2020 Nov; 477(5):717-724. PubMed ID: 32435886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
    Horn LC; Schreiter C; Canzler A; Leonhardt K; Einenkel J; Hentschel B
    Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.
    Ricciardelli C; Brooks JH; Suwiwat S; Sakko AJ; Mayne K; Raymond WA; Seshadri R; LeBaron RG; Horsfall DJ
    Clin Cancer Res; 2002 Apr; 8(4):1054-60. PubMed ID: 11948113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.
    Catteau X; Simon P; Noël JC
    BMC Cancer; 2014 Jul; 14():499. PubMed ID: 25011545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).
    Dales JP; Garcia S; Carpentier S; Andrac L; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Taranger-Charpin C
    Br J Cancer; 2004 Mar; 90(6):1216-21. PubMed ID: 15026804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.
    de Kruijf EM; van Nes JG; van de Velde CJ; Putter H; Smit VT; Liefers GJ; Kuppen PJ; Tollenaar RA; Mesker WE
    Breast Cancer Res Treat; 2011 Feb; 125(3):687-96. PubMed ID: 20361254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.
    Sjöberg E; Augsten M; Bergh J; Jirström K; Östman A
    Br J Cancer; 2016 May; 114(10):1117-24. PubMed ID: 27115465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome.
    Yamashita M; Ogawa T; Zhang X; Hanamura N; Kashikura Y; Takamura M; Yoneda M; Shiraishi T
    Breast Cancer; 2012 Apr; 19(2):170-6. PubMed ID: 20978953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts.
    Niemiec JA; Adamczyk A; Ambicka A; Mucha-Małecka A; M Wysocki W; Ryś J
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):10-6. PubMed ID: 23455186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Andrac-Meyer L; Ramuz O; Lavaut MN; Allasia C; Charpin C
    Am J Clin Pathol; 2003 Mar; 119(3):374-80. PubMed ID: 12645339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.